Although further studies are needed to elucidate the detailed mechanisms by how NCX1-mediated Ca2+ entry induces human ESCC, our study has provided a novel perspective that targeting NCX1 may be a potential therapeutic strategy for ESCC. Here, SLC8A1 is linked to esophageal squamous cell carcinoma.